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The immune system is suggested to be essential in vascular remodeling and
stiffening. To study the dependence upon lymphocytes in vascular stiffening, we
compared an angiotensin II-model of vascular stiffening in normal C57BL/6J mice with
lymphocyte-deficient RAG 1−/− mice and additionally characterized the component of
vascular stiffness due to vasoconstriction vs. vascular remodeling. Chronic angiotensin
II increased aortic pulse wave velocity, effective wall stiffness, and effective Young’s
modulus in C57BL/6J mice by three-fold but caused no change in the RAG 1−/− mice.
These functional measurements were supported by aortic morphometric analysis.
Adoptive transfer of CD4+ T helper lymphocytes restored the angiotensin II-mediated
aortic stiffening in the RAG 1−/− mice. In order to account for the hydraulic vs. material
effects of angiotensin II on pulse wave velocity, subcutaneous osmotic pumps were
removed after 21 days of angiotensin II-infusion in the WT mice to achieve normotensive
values. The pulse wave velocity (PWV) decreased from three- to two-fold above baseline
values up to 7 days following pump removal. This study supports the pivotal role of the
CD4+ T-lymphocytes in angiotensin II-mediated vascular stiffening and that angiotensin
II-mediated aortic stiffening is due to the additive effect of active vascular smooth muscle
vasoconstriction and vascular remodeling.
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Introduction
Progressive aortic stiffening predisposes individuals to cardiac, cerebral, and renal dysfunction
(Boutouyrie et al., 2002; Han et al., 2013; Tsao et al., 2013; Yoon et al., 2013). A mechanism
of injury suggests that arterial stiffening increases pulsatile flow and pressure patterns, thereby
injuring the microvasculature of highly perfused organs, particularly the brain and kidneys. In
addition, stiffening causes the incident and reflected flow and pressure waves to travel faster, leading
to early return of the reflected waves that functionally cause increased left-ventricular afterload
and eventually diastolic dysfunction. Due to the wide array of diseases attributed to this vascular
condition, there is a recognized clinical need to investigate the pathogenesis of arterial vascular
stiffening and to provide research lines that will reduce the disease burden caused by vascular
stiffness.
Functional or effective arterial stiffness is determined in the human primarily with pulse wave
velocity (PWV) and in the rodent models with ex vivo stress/strain determination. The in vivo
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PWV measurements blend the effects of vascular pressure,
vascular smooth muscle (VSMC) tone, pre-strain, and diameter
with the material composition of the extracellular matrix (ECM)
in the determination of vascular stiffness. Conversely, ex vivo
measurements using sequential biaxial loading includes the
passive biomechanical properties that relate to ECM material
composition. It has been recently noted that the VSMCs play
an active role in and are integral regulators of aortic stiffness
which is generally not characterized in the experimental models
using ex vivo biomechanical analyses (Saphirstein and Morgan,
2014). Thus, both acceptedmethods of assessing vascular stiffness
using in vivo PWV and ex vivo biaxial biomechanics provide
descriptive data regarding vascular stiffness but are limited in
their ability to differentiate VSMC contribution separately from
the ECM biomaterial composition to vascular stiffness.
VSMC responses to angiotensin II (Ang II) infusion appear
to be independent of adaptive immunity (Majeed et al., 2014).
However, the ECM material composition and function is
dependent upon the competence of the adaptive immune system.
Furthermore, the adaptive immune system has been shown to
be an important component of Ang II-related vascular disease.
RAG 1−/−mice, lacking T- and B-lymphocytes, have been shown
to exhibit blunted responses to Ang II in hypertension and
vascular stiffness (Guzik et al., 2007; Wu et al., 2014). However,
there is a requirement to integrate VSMC responses with ECM
remodeling responses to appreciate the vascular mechanics and
physiology.
T cells have been shown to increase vascular remodeling in
RAG 1−/− mice and stiffness as measured by ex vivo stress–
strain relationships (Wu et al., 2014). We sought to confirm
these findings in a clinically relevant method of measuring
stiffness: PWV. We also investigated the diastolic flow fraction
and reflective wave propagation of the aortic flow Doppler to
further characterize the effects of stiffening on arterial function.
In this study, we assess the effect of changes in blood pressure
and ECM remodeling by collagen deposition as they contribute
to in vivomeasurements of vascular stiffness. Moreover, we show
specifically that CD4+ T cells support the vascular stiffening
process.
Methods
Animals
C57BL/6J, RAG 1−/−, and CD8−/− male mice (8-week old) were
obtained from the Jackson Laboratories (Bar Harbor, ME, USA).
All of mice used in this study were of C57BL/6J background.
This study was approved by the University of Arizona Animal
Care Committee and conforms to the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85-23, revised 1996). All the
mice were maintained in the animal facility of the University
of Arizona and fed with NIH-31 Modified Open Formula
Mouse/Rat Sterilizable Diet from Harlan Laboratories. The mice
were treated with [Val5]angiotensin II (Ang II) (Sigma-Aldrich)
at 490 ng/min/kg via subcutaneously implantable osmotic pumps
(model 1004; Alzet, Palo Alto, CA, USA). The mice were then
monitored for up to 21 days of Ang II infusion until sacrifice.
Tail Cuff
All mice were trained with the tail cuff system (Hatteras
Instruments, Cary, North Carolina) and data were recorded for
days 0, 7, 14, and 21. Tail cuff measurements were performed
with the mice on a heated platform. Blood pressure values were
recorded from an average of 10 consecutive measurements with
standard deviation lower than 10.
ECHO/Doppler
PWV, reflective wave, and diastolic flow fraction were calculated
from noninvasive ECHO Doppler measurements acquired with
the Vevo 770 High Resolution Imaging System (VisualSonics,
Toronto, Canada). Estimation of wall stiffness, Eh, Young’s
modulus, E, and wall thickness, h, were derived from the Moens–
Korteweg equation for PWV. Detailed methods are described
previously (Eberson et al., 2015).
Diastolic Flow Fraction and Reflective Wave
Diastolic flow fraction was calculated as the percentage of the
velocity-time integral of the Doppler trace of the aortic flow wave
in diastole superior to the renal bifurcation. Reflected flow waves
have the same shape as the pressure waves but are 180◦ out of
phase (Westerhof et al., 1972). We measured the distance from
the EKG R-wave to the initial beginning of the innominate lower
extremity flow wave (Heffernan et al., 2013) and presented it as
the transit time of the reflective wave (ms).
Perfusion Fixation and Histological Staining
Before perfusion fixation, mice were injected with 100µl
of 1000 USP units/ml Heparin sodium. Thirty milliliters of
saline was infused to remove vascular blood, followed by
the administration of 2:1 3% glutaraldehyde:1% formaldehyde
solution at a constant aortic perfusion pressure of 40mmHg
for 15min. This technique reduces fixation contraction. Aortic
tissues were paraffin embedded, cut at 5µm, and stained with
Masson’s Trichrome and Picrosirius red for morphology and
collagen assessment with NIH ImageJ. The area of Picrosirius red
staining was normalized to the lumen diameter.
T Cell Isolation and Adoptive Transfer
Enriched T cells were isolated from spleens and lymph nodes of
CD8−/− C57BL/6 mice (red blood cell lysis followed with IgG
panning). Flow cytometry was used to confirm 98% purity of
CD4+ T lymphocytes. 2×107 isolated CD4+ T cells were injected
intra-peritoneally into each RAG 1−/− mouse 2 weeks prior to
Ang II administration.
Flow Cytometry
Isolated lymphocytes were stained with cell surface antibodies.
Efluor 450-conjugated anti-CD3, APC-conjugated anti-CD19,
Efluor450-conjugated anti-CD4, and FITC-conjugated anti-
CD8a were purchased from eBioscience. The BD LSR II with BD
FACSDiva software was used to analyze data.
Statistics
All data are reported as means ± SEM. Comparisons among the
defined groups were analyzed by One-Way ANOVA, followed by
Tukey multiple comparisons tests using GraphPad Prism. P <
0.05 was considered statistically significant.
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Results
Aortic Stiffness is Reduced in RAG 1−/− Mice
We first determined if immunodeficient RAG 1−/− mice
lacking mature T- and B-lymphocytes would demonstrate
aortic vascular stiffness comparable with that of strain-matched
immunocompetent mice. Central aortic stiffness was measured
by PWV in WT and RAG 1−/− mice. Baseline PWV-values were
similar in WT and RAG 1−/− mice (2.3 ± 0.4 vs. 2.6 ± 0.3 m/s).
With chronic Ang II infusion, PWV increased in WT mice to
6.5 ± 0.6m/s by day 21 but no increase in PWV was detected in
the RAG 1−/−mice (Figure 1A). Similarly the calculated effective
wall stiffness (Eh) increased in the WT but not in the RAG 1−/−
mice (Figure 1B). Aortic wall thickness (h) increased in both
strains but this increase was significantly reduced in the RAG
1−/− mice (Figure 1C). Finally, effective Young’s modulus (E)
increased over the 21-day treatment of Ang II in the WT but
not in the RAG 1−/− mice (Figure 1D). Additional parameters
of stiffness using aortic flow Doppler were measured. WT mice
exhibited a significant decrease in diastolic flow fraction by day
21, while RAG 1−/− showed no significant change (Figure 1E).
This decrease in diastolic flow percentage of the Doppler trace
is related to the loss in Windkessel function of the aorta with
chronic Ang II treatment. Additionally, the transit time of the
FIGURE 1 | Stiffness measurements. Mice were treated with [Val5]Ang II
at 490 ng/kg/min for 3 weeks. (A) Pulse wave velocity (PWV) in response to
Ang II treatment between WT and RAG 1−/− mice was measured. PWV was
used to calculate (B) effective wall stiffness, (C) wall thickness, and (D)
effective Young’s modulus, E. (E) Diastolic flow fraction was calculated as the
diastolic percentage of the velocity-time-integral (VTI) in the aortic Doppler
flow wave. (F) Reflective wave represents the transit time of the intersection
of the forward and reflective flow waves from the R wave of the EKG.
*P < 0.05 to day 0 WT; †P < 0.05 to WT at respective time point. N = 4–22.
Data are means ± SEM.
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reflective wave was reduced by day 21 inWTmice but not in RAG
1−/− mice (Figure 1F). This is supported by a change in flow
wave reflection with vascular stiffness (Murgo et al., 1981). The
unexpected difference in reflective wave at day 0 could possibly
be due to developmental differences between the strains.
The increase in the effective Young’s modulus in the WT
group is dependent upon the material composition and/or
mechanical properties of the wall rather than the changes in
vascular morphometric properties. Furthermore, the Ang II-
mediated increase in Young’s modulus in the WT but not in the
RAG 1−/− mice in response to Ang II implies its dependency
upon immune cells.
Blood Pressure in WT and RAG 1−/− Mice
Blood pressure was measured in mice receiving chronic Ang II
infusion.WT and RAG 1−/−mice exhibited a significant increase
in systolic blood pressure as measured by tail cuff over 21 days
(Figure 2). By 14 days, RAG 1−/− mice had an average systolic
pressure that was significantly lower than that of WT (158 ±
4.7 vs. 175 ± 3.8mmHg). The difference in pressures remained
significant at 21 days (161± 10.7 vs. 191± 5.0mmHg).
The Ang II-induced Increase in In vivo Measures
of Stiffness is due to Vascular Remodeling
In order to account for the differential effects of Ang II on PWV,
namely vasoconstriction as opposed to vascular remodeling, we
removed the subcutaneous osmotic pumps after 21 days of Ang
II infusion in the WT mice. Systolic blood pressure dropped
immediately to normotensive values 1 day after pump removal
(Figure 3A). Following the three-fold increase in PWV values
with 21 days of Ang II administration, PWV remained two-fold
above baseline values at 1, 4, and 7 days after pump removal
(Figure 3B). Pumps were also removed after treatment in RAG
1−/− but no changes were observed in PWV (data not shown).
Diastolic flow fraction remained significantly lower than baseline
values 1 day after pump removal (Figure 3C), although reflective
wave showed no significant differences after Ang II stimulus-
removal compared to baseline levels (Figure 3D).
Taken together, these data reveal that under the conditions
described above the functional measurement of vascular stiffness
FIGURE 2 | Blood pressure. Systolic blood pressures were measured by tail
cuff in WT and RAG 1−/− over the [Val5 ]Ang II treatment. N = 15–47.
*P < 0.05 vs. day 0 of WT; #P < 0.05 vs. day 0 of RAG 1−/−; †P < 0.05
between different strains at each time point. Data are means ± SEM.
is due to both the vasoconstrictive effect of Ang II and
Ang II-mediated vascular remodeling. These pump removal data
are consistent with a recent report supporting the significant role
of vascular smooth muscle in vascular stiffening (Saphirstein and
Morgan, 2014).
Ang II-induced Vascular Remodeling is Reduced
in RAG 1−/− Mice
Histological evaluation of aortas was performed in WT or RAG
1−/− mice and representative sections are shown in Figure 4A.
WT mice exhibited a significant increase in medial thickness by
14 days (Figure 4B). This increase, however, was significantly
less prominent in RAG 1−/− mice in comparison with WT mice
(Figure 4B). The adventitial thickness increased significantly by
day 21 in the WT mice but did not change in the RAG 1−/−
mice in comparison with the controls (Figure 4C). Collagen
levels, represented by the collagen:lumen ratio as quantified by
PSR staining, increased in the WT mice by day 14 but were
not significantly increased in the RAG 1−/− mice (Figure 4D).
Additionally, 7 days after pump removal at 21 days of Ang II
treatment, adventitial thickness and collagen content returned to
day 0 levels. Only medial thickness remained significantly higher
than control levels. These results indicate that aortic remodeling
is significantly reduced in RAG 1−/− mice in response to chronic
Ang II infusion. These results further indicate a reversal of
histological remodeling in the aorta after removal of the Ang II
stimulus.
Adoptive Transfer of CD4+ T Lymphocytes
Restores PWV in RAG 1−/− Mice
CD4+ T cells have been shown to be important in atherosclerosis
(Dinh et al., 2012) and Ang II-induced thrombus formation
(Senchenkova et al., 2011). Since RAG 1−/−mice lack an adaptive
immune system, including CD4+ T helper cells, we investigated
whether adoptive transfer of CD4+ lymphocytes could restore
vascular stiffness in response to Ang II. CD4+ cells were isolated
from CD8−/− mice and purified by IgG panning and 2 × 107
cells were injected i.p. into RAG 1−/− mice. Reconstitution was
allowed to occur for 2 weeks; followed by infusion of Ang II.
In order to account for diminishing numbers of transferred
cells, mice were sacrificed after 2 weeks of Ang II infusion.
Representative flow cytometry confirms adoptive transfer of
CD4+ T cells that was devoid of cytotoxic T cells, characterized
by CD8, or B cells, characterized by CD19 (Figure 5A).
CD4+ T cells did not significantly alter the arterial blood
pressure in RAG 1−/−mice (Figure 5B). However, PWV
increased significantly by 14 days in the RAG 1−/−mice
receiving CD4+ lymphocytes (Figure 5C). The calculated wall
stiffness increased in the RAG 1−/− mice receiving CD4+ cells
(Figure 5D), but wall thickness was not significantly affected
(Figure 5E). Most importantly the effective Young’s modulus
also increased with CD4+ adoptive transfer in mice receiving
Ang II (Figure 5F). Histological evaluation of aortic samples at
14 days of Ang II infusion showed no significant differences
medial or adventitial thicknesses or collagen content in the vessels
(Figures 5G–J). Therefore, adoptive transfer of T-lymphocytes
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FIGURE 3 | Pump removal. (A) After 21 days of Ang II treatment, the
osmotic pumps releasing Ang II were removed and systolic blood
pressure was measured 1, 4, and 7 days thereafter. Stiffness parameters
of PWV (B), diastolic flow fraction (C), and reflective wave (D) were also
measured. *P < 0.05 vs. day 0; †P < 0.05 vs. day 21. N = 4–6. Data are
means ± SEM.
FIGURE 4 | Histomorphometrics of aortic cross-sections.
Representative trichrome images show aortic remodeling over the time
course of Ang II treatment in WT and RAG 1−/− mice and after pump
removal in WT mice (A). Medial (B) and adventitial (C) thicknesses were
calculated using the trichrome stain. The ratio of collagen cross-sectional
area to lumen area was measured by Picrosirius red staining (D). *P < 0.05
vs. day 0 of WT; #P < 0.05 vs. day 0 of RAG 1−/−; †P < 0.05 between
different strains at each time point. N = 6. Data are means ± SEM.
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FIGURE 5 | Adoptive transfer of CD4+ T cells to RAG 1−/− mice. CD4+
T cells were isolated from CD8−/− mice and adoptively transferred to RAG
1−/− mice. (A) Representative splenic flow cytometry 2 weeks after adoptive
transfer of CD4+ T cells to RAG 1−/− mice is displayed. Systolic blood
pressure measurements by tail cuff (B) were made in RAG 1−/− with
adoptively transferred CD4+ T cells and stiffness was measured by pulse
wave velocity (C). Parameters in (D–F) are at 14 days of Ang II, including (D)
effective wall stiffness, (E) wall thickness, and (F) effective Young’s modulus.
Representative trichrome images (G) are presented of aortic cross-sections
from RAG 1−/− mice with adoptive transfer of CD4+ T cells followed by (H)
medial and (I) adventitial thicknesses and (J) collagen:lumen ratio. *P < 0.05
vs. day 0 of RAG 1−/− in (B); *P < 0.05 vs. WT in (D–F); †P < 0.05 vs. RAG
1−/−. N = 6–8. Data are means ± SEM.
reconstituted the ability of immune deficient mice to develop
functional aortic vascular stiffness.
Discussion
Vascular stiffness is an important predictor of cardiovascular
disease events. Therefore, the elucidation of its mechanisms
is imperative (Mitchell et al., 2010). Our study indicates
that vascular stiffness is dependent on the collagen-mediated
remodeling that is in-turn reliant on the adaptive immune
system. Moreover, adoptive transfer of CD4+ T cells is able
to restore stiffness in immunodeficient mice. We found in
this study that histological parameters of aortic remodeling,
namely increased collagen deposition as well as medial
hypertrophy and adventitial fibrosis corresponded to an increase
in PWV in immunocompetent WT mice over the period
of chronic Ang II infusion. Furthermore, RAG 1−/− mice
displayed blunted histological remodeling and no increase
in PWV despite a significant increase in the arterial blood
pressure. These results are reinforced by a decrease in the
diastolic fraction of the Doppler flow wave in the WT
but not the RAG 1−/− mice, supportive of a loss of
Windkessel function in the immunocompetent mice. Moreover,
the reflective wave propagation time decreased with Ang II
administration in theWT but not the RAG 1−/− mice, indicating
increased wave reflection toward the heart in the WT mice.
Increased wave reflection, in addition to arterial stiffening, is
predictive of future cardiovascular disease events (Sung et al.,
2012).
The results of our study support those of Wu et al. (2014),
in which it was found that Ang II-induced aortic stiffening as
measured by ex vivo biomechanical analysis was significantly
increased in WT mice compared with immunodeficient RAG
1−/−mice. However, contrary to their results, we have found
that blood pressure increased significantly in the RAG 1−/−
mice in response to [Val5]Ang II treatment. The PWV increased
in the WT, did not change in the RAG 1−/−mice, and
with reconstitution of the adaptive immune system the PWV
increased to values similar to that of the WT mice receiving
Ang II. Most notably, our functional stiffness measurements in
RAG 1−/− mice as measured by PWV include contributions
of both active smooth muscle and structural alterations on
vascular stiffening in a living system. This differs from biaxial
biomechanical measurements, which only provide information
on structural and material changes and are not translatable
to the clinical setting. Our results showing that ablation of T
lymphocytes, major constituents of adaptive immunity, prevents
the development of aortic stiffening is consistent with a study
showing that immunosuppression by Tregs reduces Ang II-
induced stiffening in small arteries (Barhoumi et al., 2011) and
large arteries (Majeed et al., 2014).
An interesting finding in our study is that pump removal after
21 days of Ang II treatment reduced PWV in theWTmice but the
PWV stayed significantly elevated over pretreatment values. We
suggest that this PWV level post-treatment is due to structural
and material remodeling of the vessel wall. However, RAG 1−/−
mice did not exhibit raised PWV at all despite the effect of Ang
II in raising blood pressure in this group significantly over the 3-
week treatment. If the decrease in WT PWV after pump removal
was due to the vasoconstrictive and blood pressure raising effects
of Ang II, then that raises the question of why the RAG 1−/−
mice did not exhibit even a blunted increase in PWV over the
treatment period. One possible explanation for this phenomenon
is cellular repositioning of the smooth muscle that occurs in the
WT mice (Martinez-Lemus et al., 2009) and altered interactions
between the ECM and the smooth muscle (Schiffrin, 2012).
Moreover, vascular stiffening and hypertension might not always
be related (Weisbrod et al., 2013). These possibilities must be
investigated in future studies.
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In order to further explore to the question of whether
heightened blood pressure and vascular stiffening are related,
Wu et al. (2014) utilized hydralazine and hydrochlorothiazide
to prevent the Ang II-mediated increase in blood pressure
and found no resulting increase in vascular stiffness. Although,
they concluded from these observations that blood pressure
and mechanical stress alone could cause vascular stiffening,
hydralazine has anti-neoplastic properties and prevents tissue
growth since it is a non-nucleoside DNA methyltransferase
(DNMT) inhibitor (Graca et al., 2014). Therefore, hydralazine’s
potential anti-proliferative effect as a DNMT inhibitor is a
confounding factor for the interpretation of these results.
Moreover, we have found in our study that the RAG 1−/− mice
do not exhibit an increase in aortic stiffness despite a significant
elevation in blood pressure.
In our study, CD4+ T cells were able to restore the Ang II-
induced increase in PWV in RAG 1−/− mice but were not able
to change collagen levels or aortic morphometry by histology.
Our histological findings are consistent with Wu et al. (2014).
However, this group did not find a restoration of stiffness with
CD4+ T lymphocyte adoptive transfer to RAG 1−/− mice.
Differences may be due to differing methods used to purify and
adoptively transfer CD4+ T cells and to measure aortic stiffness.
Mechanisms for this restoration of Ang II-induced arterial
stiffening by CD4+ T cells could involve increases in crosslinks,
such as advanced glycation end-products that are known to
reduce arterial compliance (Kass et al., 2001). Enzyme-mediated
crosslinks such as those by lysyl oxidases and transglutaminases
that can lead to stiffening (Schiffrin, 2012; Eberson et al., 2015)
may also be regulated by CD4+ T cells. Further mechanisms
could include upregulation of inflammatory mediators such as
adhesion molecules, cytokines, and intracellular transcription
factors as well as mediators of oxidative stress. Adding
on, remodeling of the extracellular matrix, whose fibrillar
components create altered interactions with smooth muscle cells,
could facilitate reduction of vascular distensibility (Schiffrin,
2012).
The contribution of the immune system to vascular stiffening
is indeed a critical area of investigation that is important for the
clinical setting. It has been shown that reduced carotid arterial
distensibility among HIV-infected women, adjusted for age, HIV
medications, and vascular risk factors, is associated with higher
frequencies of CD4+CD38+HLA−DR+ T cells (Kaplan et al.,
2011). This suggests that pro-inflammatory T cells may produce
vascular remodeling in HIV-infected patients leading to arterial
stiffening. In another clinical example, rheumatoid arthritis (RA)
in young patients is associated with shortened pulse propagation
time (Yildiz et al., 2004) and anti-tumor necrosis factor α therapy
reduces aortic stiffening and inflammation in RA patients (Maki-
Petäjä et al., 2012).
In summary, we have shown that vascular stiffness does not
increase in response to Ang II treatment in RAG 1−/− mice
despite an increase in blood pressure. Furthermore, adoptive
transfer of CD4+ T cells restores the Ang II-mediated increase
in aortic stiffness. Our results use in vivo measures of vascular
stiffening in mice and support the role of the adaptive immune
system, specifically CD4+ T cells, in the development of vascular
stiffness and show a disparity in the role of blood pressure
regulation on vascular stiffness.
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